Replies to post #238985 on Avid Bioservices Inc (CDMO)

[BioBS2012]

It means more time to guess at outcome,how much money will be needed to run trial(s),how much will come from ATM,etc.

I don't know how much money will be needed for running these trials but what is for sure is that (a) it will be less then what would have been required if Opdivo was the combo drug, (b) now we can also assume reduced time for trial completion, (c) trial sites are already wetted with the SUNRIS trial ongoing so should be a "seamless" transition to these combo trials at the sites chosen. Again it is global, under PPHM control - less money, less time. POSTIVE. POSITIVE

Cheers.